Skip to contentO
Oragenics Inc
O
OGENOragenics Inc Q2 2026 · 10-Q
Revenue—
Net Income-$2.53M-$2.53MN/M vs Q2 2025 EPS Diluted-$0.57-$0.57N/M vs Q2 2025 Operating Income-$2,592,528N/M Operating Cash Flowderived-$2,186,760N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Oragenics Inc · CIK 1174940 · Engraved from SEC EDGAR
ended Jun 30, 2026 · filed Aug 13, 2026 · 44 d after period end